Abstract: Provided are an antibody binding to GPRC5D and a use thereof. Specifically provided are an anti-GPRC5D antibody and an antigen-binding fragment thereof, a nucleic acid encoding same, a vector comprising the nucleic acid, a cell comprising the vector, and a pharmaceutical composition comprising same. Further provided is a use thereof in reducing tumors or inhibiting tumor cell growth, treating diseases, etc.

Abstract: Provided are an anti-CD40 antibody and a use thereof, such as a mouse, human, chimeric, or humanized antibody specifically binding to CD40, and an antigen-binding fragment thereof, and further provided are a nucleic acid molecule encoding the antibody or the antigen-binding fragment thereof, and an expression vector and a host cell for expressing the antibody or the antigen-binding fragment thereof. Further provided are a preparation method and a use method for the antibody or the antigen-binding fragment thereof, comprising treating and preventing immune diseases.

Abstract: An anti-IL-36R antibody and a use thereof, in particular, a mouse, chimeric or humanized antibody or an antigen-binding fragment thereof binding to IL-36R; a nucleic acid molecule encoding the antibody or the antigen-binding fragment thereof, as well as an expression vector and host cell used to express the antibody or the antigen-binding fragment thereof. In addition, a preparation method and a use of the antibody or the antigen-binding fragment thereof, including treatment and prevention of IL-36/IL-36R-mediated diseases and disorders.

Abstract: Provided are an anti-Claudin18.2 antibody or an antigen binding fragment thereof, a pharmaceutical composition comprising an anti-Claudin18.2 antibody or an antigen binding fragment thereof, and uses thereof. The antibody and Claudin18.2 have significant binding activity and affinity, have efficient in-vitro ADCC cytotoxic activity against a tumor cell, and can be applied in the preparation of an antineoplastic drug.

Abstract: There is provided a screen scattering system. The system has a transparent substrate forming a substrate layer, and wide band gap materials made of 0D, 1D and 3D elements forming a scattering layer. The 0D, 1D and 3D elements are in the form of nanostructures aligned uniformly on said substrate layer.

Abstract: There is provided a screen scattering system. The system has a transparent substrate forming a substrate layer, and wide band gap materials made of 0D, 1D and 3D elements forming a scattering layer. The 0D, 1D and 3D elements are in the form of nanostructures aligned uniformly on said substrate layer.